SecBot SecBot
SECBOTREPLAY Home › Report › XOMA

XOMA · XOMA Royalty Corp announced that the previously announced acquisition…

XOMA Royalty Corp · 8-K filed Jun 12, 2026 at 17:22 ET

At the news

NEUTRALIMPACT 4/10

8-K filed Jun 12, 2026 at 17:22 ET

XOMA Royalty Corp announced that the previously announced acquisition by Ligand Pharmaceuticals is expected to close on or about July 14, 2026, and simultaneously called for full redemption of its two outstanding perpetual preferred stock series (XOMAP and XOMAO) at $25 per share/share-equivalent plus accrued dividends, effective the same date. The redemption is a direct consequence of the pending merger, and a CVR record date for common stockholders was also set for July 13, 2026.

  • Merger with Ligand expected to close on or about July 14, 2026
  • All 984,000 shares of 8.625% Series A Preferred (XOMAP) and 1,760,500 depositary shares of 8.375% Series B Preferred (XOMAO) to be redeemed at $25.00 each on July 14, 2026
  • Final quarterly dividends declared: $0.53906 per Series A share, $0.52344 per Series B depositary share, payable July 15 to record holders of July 2
  • CVR record date for common stockholders set at 5:00 p.m. ET on July 13, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access